A new variation of a therapy used to treat X-linked severe combined immunodeficiency syndrome uses a genetically engineered virus to help the body create disease-fighting T-cells. David A. Williams, Leland Fikes Professor of Pediatrics at Boston Children’s Hospital, coauthored the study.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?